Study links protein to MDS survival rate, progression to AML

10/6/2011 | MDSBeacon.com

Taiwanese researchers have discovered that people with myelodysplastic syndromes who have lower levels of the angiopoietin-1 protein were less likely to progress to acute myeloid leukemia and survived longer compared with patients who had higher levels of the protein. The protein plays a role in the formation of new blood vessels, according to the study published in the British Journal of Cancer.

View Full Article in:

MDSBeacon.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX